Immunotech Biopharm Market Cap

Immunotech Biopharm has a market cap or net worth of 358.15 million as of June 17, 2026. Its market cap has decreased by -80.72% in one year.

Market Cap

358.15M

Enterprise Value

672.43M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.54

Market Cap Chart

Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 358.15M, a decrease of -95.37%. That is a compound annual growth rate of -40.41%.

Market Cap History

Date	Market Cap	% Change
Jun 16, 2026	351.98M	-80.55%
Dec 31, 2025	1.81B	52.87%
Dec 31, 2024	1.18B	-54.00%
Dec 29, 2023	2.57B	7.99%
Dec 30, 2022	2.38B	-72.51%
Dec 31, 2021	8.67B	50.90%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Jul 10, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cloudbreak Pharma	1.02B
Sunho Biologics	970.43M
Wuhan YZY Biopharma	775.40M
3D Medicines	723.01M
Brii Biosciences	707.37M
JW (Cayman) Therapeutics Co.	669.73M
Transcenta Holding	635.70M
Shanghai Bio-heart Biological Technology	591.50M

Market Cap Rankings